Loading…
Loading…
HDII does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for HDII and 80,000+ other tickers.
See exactly how HDII's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for HDII and 80,000+ other tickers.
Hypertension Diagnostics, Inc. (HDII) is a company that designs, develops, manufactures, and commercializes its own innovative, non-invasive medical technologies. These devices are engineered to identify minute changes in the flexibility of arteries, serving both domestic and international markets. Central to their offerings is the CVProfilor, a system designed for non-invasive assessment of both large and small artery elasticity. The elasticity of small arteries is especially critical, serving as the earliest and most sensitive indicator of cardiovascular disease. The product suite includes…
